Seçil ALDEMİR, Seval ERPOLAT, Seda TAN, Ercan DALBUDAK, MERVE TOPCU

Diffüz alopesili kadınlarda öfke, anksiyete ve depresyon

Amaç: Bu çalışmada diffüz alopesili hastalarda psikiyat- rik belirti sıklığının sağlıklı kontrollere göre daha fazla olup olmadığının belirlenmesi ve bunların öfke düzeyle- riyle ilişkisinin araştırılması amaçlanmıştır. Yöntemler: Bu çalışmaya dermatoloji polikliniğinde diffüz alopesi tanısı konulan 43 kadın hasta ile cinsiyet ve yaş açısından uyumlu sağlıklı 52 gönüllü dâhil edildi. Derma- tolojik tanı olarak diffüz alopesi alt tiplerinden androgene- tik alopesi tanısı alan 19 (%20,0), diffüz alopesia areata tanısı alan 10 (%10,5), telogen effluvium tanısı alan 14 (%14,7) kişi çalışmaya dâhil edildi. Hastalara ve kontrol grubuna Hastane Anksiyete ve Depresyon Ölçeği (HAD) ve Sürekli Öfke ve Öfke Tarz Ölçeği (SÖÖTÖ) uygulandı. Standart hazırlanan Saç Dökülmesi Hasta Takip Formu- na hastaların kayıtları yapıldı. Bulgular: Alopesili hasta grubunda sağlıklı kontrollere göre anksiyete (p

Anger, anxiety and depression in females with diffuse alopecia

Objective: Present study aims to compare control group patients and patients with diffuse alopecia in order to un- derstand the nature of the relationship between symp- toms and level of anger and to see whether patient group has higher number of symptoms than control group. Methods: 43 female patients who were diagnosed dif- fuse alopecia in dermatology clinic and 52 age-and- gender-matched control participants were included in the study. 20% of patients (n=19) with androgenetic alope- cia, 10.5% of patients (n=10) with diffuse alopecia areata and 14.7% of patients (n=14) with telogen effluvium par- ticipated in study. Hospital Anxiety and Depression Scale (HADS) and The Trait Anger and Anger Expression Scale (TAAES) were filled by the participants. Also patients were followed up by a standard hospital form recording alopecia. Results: It was found that patients with alopecia revealed significantly more depression (p<0,001) and anxiety (p<0,001) scores than control group. Also trait anger (β = 0,216, Wald Z = 3,697, Exp(B)= 1,241, p<0,05) and anxi- ety (β = -0.466, Wald Z = 5,008, Exp(B)= 0.628, p<0,05) scores significantly predicted alopecia group. Additionally total time period for alopecia significantly and positively correlated with depression (r= 0,402, p<0.01) and anxiety (r=0,393, p<0,01) scores. Comparing patient groups with each other, trait anger and expressed anger were signifi- cantly different across groups. Conclusion: Patient group reported more anxiety and depressive symptoms than control group. In treatment of patients with alopecia, bidirectional relationship between alopecia and psychological symptoms should be in con- sideration. Collaboration with psychiatry is suggested in order to improve treatment efficacy and patients life sat- isfaction. In addition anger management seems essential in treatment of patients with diffuse alopecia

PDF

___

1. Biondo S, Goble D, Sinclair R. Women who present with female pattern hair loss tend to underestimate the severity of their hair loss. Br J Dermatol 2004;150:750-752. 2. Wolff H. Diseases of hair. Braun-Falcos Dermatology. Ed. Burgdorf WHC, Plewig G, Wolff HH, Landthaler M, Braun-Falco O. 3rd ed. Italy, Springer, 2009;1029-1059. 3. Firooz A, Firoozabadi MR, Ghazisaidi B, Dowlati Y. Con- cepts of patients with alopecia areata about their disease. BMC Dermatol 2005;5:1. 4. Cash TF, Price VH, Savin RC. Psychological effects of an- drogenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol 1993;29:568-575. 5. Werner B, Mulinari-Brenner F. Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alo- pecia areata--part II. An Bras Dermatol 2012;87:884-890. 6. Chartier MB, Hoss DM, Kels JMG. Approach to the adult female patient with diffuse nonscarring alopecia. J Am Acad Dermatol 2002;47:809-818. 7. Harrison S, Sinclair R. Telogen Effluvium. Clin Exp Derma- tol 2002;27:389-395. 8. Baranda L, Layseca-Espinosa E, Abud-Mendoza C, Gonzàlez- Amaro R. Severe and unresponsive HIV-associ- ated alopecia areata successfully treated with thalidomide. Acta Derm Venereol 2005;85:277278. 9. Trueb RM. Diffuse hair loss in women. Ther Umsch 2002;59:217222. 10. Price VH. Androgenetic alopecia in women. J Invest Der- matol 2003;8:24-27. 11. Trueb RM. Systematic approach to hair loss in women. J Dtsch Dermatol Ges 2010;8:284-297. 12. Harth W, Blume-Peytavi U. Psychotrichology: psycho- somatic aspects of hair diseases. J Dtsch Dermatol Ges 2013;11:125-135. 13. Schmidt S, Fischer TW, Chren MM, et al. Strategies of cop- ing and quality of life in women with alopecia. Br J Derma- tol 2001;144:1038-1043. 14. Ruiz-Doblado S, Carrizosa A, García-Hernández MJ. Alo- pecia areata: psychiatric comorbidity and adjustment ofil- ness. Int J Dermatol 2003;42:434-437. 15. Camacho FM, Hernandez MJG. Psychological features of androgenetic alopecia. J Eur Acad Dermatol Venereol 2002;16:476-480. 16. Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: Stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Der- matol 2004;123:455457. 17. Altınöz AE, Taşkıntuna N, Altınöz ST, Ceran S. A cohort study of the relationship between anger and chronic sponta- neous urticaria. Adv Ther 2014;31:1000-1007. 18. Bağcıoğlu E. Akne vulgariste psikolojik faktörlerin rolü, hastalığın yaşam kalitesi üzerine etkisi. Yayımlanmamış Uzmanlık Tezi, Sütçü İmam Üniversitesi Tıp Fakültesi Psi- kiyatri Anabilim Dalı, Kahramanmaraş, 2008. 19. Koh KB. Anger and somatization. Journal of Psychosomat- ic Research 2003;55:113. 20. Sifneos PE. Alexithymia and its relationship to hemispheric specialization, affect, and creativity. Psychiatr Clin North Am 1988;11:287-292. 21. Alfani S, Antinone V, Mozzetta A, et al. Psychological sta- tus of patients with alopecia areata. Acta Derm Venereol 2012;92:304-306. 22. Zigmond AS, Snaith RP. The hospital anxiety and depres- sion scale. Acta Psychiatr Scand 1983;67:361-370. 23. Aydemir Ö. Hastane anksiyete ve depresyon ölçeği türkçe formunun geçerlilik ve güvenilirlik çalışması. Türk Psiki- yatri Dergisi 1997;8:280-287. 24. Spielberger CD, Jacobs GA, Russell SF, Crane RJ. As- sessment of anger: The state-trait anger scale. Advances in personality assessment. Ed. Butcher JN, Spielberger CD. Hillsdale NJ, Erlbaum, 1983; 159-187. 25. Özer AK. Sürekli öfke ve öfke ifade tarzı ölçekleri ön çalışması. Türk Psikoloji Dergisi 1994;31:26-35. 26. Cash TF. The psychology of hair loss and its implications for patient care. Clin Dermatol 2001;19:161-166. 27. Cartwright T, Endean N, Porter A. Illness perceptions, cop- ing and quality of life in patients with alopecia. Br J Derma- tol 2009;160:1034-1039. 28. Gupta MA, Gupta AK, Wattell GN. Stress and alopecia areata: psychodermatologic study. Acta Derm Venereol 1997;77:296-298. 29. Mercan S, Altunay İK. Psikiyatri ve dermatolojinin ortak çalışma alanı: Psikodermatoloji. Türk Psikiyatri Dergisi 2006;17:305-313. 30. Colon EA, Popkin MK, Callies AL, et al. Lifetime preva- lence of psychiatric disorders in patients with alopecia area- ta. Comprehensive Psychiatry 1991;32:245-251. 31. Çalıkoğlu E, Alpay FB. Pruri universalis, alopecia area- ta, psoriasis vulgaris ve kronik ürtikerde Beck depre- syon, durumluluk ve süreklilik kaygı envanterlerinin değerlendirilmesi. T Klin Dermatol 2000;10:229-232. 32. Yazıcı AC, Başterzi A, Tot Acar Ş, et al. Alopesi Areata ve Aleksitimi. Türk Psikiyatri Dergisi 2006;17:101-106. 33. Tabolli S, Sampogna F, di Pietro C, et al. Health status, coping strategies and alexithymia in subjects with androge- netic alopecia: a questionnaire study. Am J Clin Dermatol 2013;14:139-145. 34. Doruk A, Tunca M, Koç E, ve ark. Psöriyazis ve alopesi areatali erkek olgularda aleksitimi, öfke-öfke ifade tarzi ve mizaç-karakter özellikleri. Turkiye Klinikleri J Med Sci 2009;29:1503-1509. 35. Greenberg SI. Alopecia areata: a psychiatric survey. Arch Dermatol 1995;72:454-457.